Is There an Association Between Chronic Pancreatitis and Pulmonary Function (RespPanc)

November 15, 2023 updated by: Lise Gluud, Copenhagen University Hospital, Hvidovre

Association Between Chronic Pancreatitis and Respiratory Dysfunction: A Prospective Cohort Study?

To evaluate pulmonary function in chronic pancreatitis compared with healthy volunteers and patients with cirrhosis.

Study Overview

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Capital Region Denmark
      • Hvidovre, Capital Region Denmark, Denmark, 2650
        • Gastrounit, Copenhagen University Hospital Hvidovre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

We plan to include patients with chronic pancreatitis, cirrhosis and healthy controls

Description

Inclusion Criteria:

  • Patients with chronic pancreatitis or cirrhosis
  • Healthy controls

Exclusion Criteria:

  • Lack of informed consent
  • Known chronic lung disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Patients and controls
Patients diagnosed with chronic pancreatitis or cirrhosis and healthy controls

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diffusion capacity of the lung for carbon monoxide
Time Frame: Three years
Lung diffusion capacity
Three years
Alveolar volume
Time Frame: Three years
Alveolar volume
Three years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2018

Primary Completion (Actual)

October 1, 2023

Study Completion (Actual)

October 1, 2023

Study Registration Dates

First Submitted

February 20, 2019

First Submitted That Met QC Criteria

February 21, 2019

First Posted (Actual)

February 22, 2019

Study Record Updates

Last Update Posted (Estimated)

November 16, 2023

Last Update Submitted That Met QC Criteria

November 15, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Subscribe